These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 11123327)
1. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470 [TBL] [Abstract][Full Text] [Related]
3. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633 [TBL] [Abstract][Full Text] [Related]
4. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge. Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584 [TBL] [Abstract][Full Text] [Related]
5. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites. Calvo-Calle JM; Oliveira GA; Nardin EH J Immunol; 2005 Dec; 175(11):7575-85. PubMed ID: 16301667 [TBL] [Abstract][Full Text] [Related]
7. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363 [TBL] [Abstract][Full Text] [Related]
8. An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses. Parra-López CA; Bernal-Estévez D; Yin L; Vargas LE; Pulido-Calixto C; Salazar LM; Calvo-Calle JM; Stern LJ PLoS One; 2014; 9(7):e100639. PubMed ID: 24983460 [TBL] [Abstract][Full Text] [Related]
9. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM Front Immunol; 2021; 12():689920. PubMed ID: 34168657 [TBL] [Abstract][Full Text] [Related]
10. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
11. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. Nardin EH; Oliveira GA; Calvo-Calle JM; Castro ZR; Nussenzweig RS; Schmeckpeper B; Hall BF; Diggs C; Bodison S; Edelman R J Infect Dis; 2000 Nov; 182(5):1486-96. PubMed ID: 11023472 [TBL] [Abstract][Full Text] [Related]
12. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750 [TBL] [Abstract][Full Text] [Related]
13. Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein. Gregson AL; Oliveira G; Othoro C; Calvo-Calle JM; Thorton GB; Nardin E; Edelman R PLoS One; 2008 Feb; 3(2):e1556. PubMed ID: 18253503 [TBL] [Abstract][Full Text] [Related]
14. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. Wang R; Epstein J; Charoenvit Y; Baraceros FM; Rahardjo N; Gay T; Banania JG; Chattopadhyay R; de la Vega P; Richie TL; Tornieporth N; Doolan DL; Kester KE; Heppner DG; Norman J; Carucci DJ; Cohen JD; Hoffman SL J Immunol; 2004 May; 172(9):5561-9. PubMed ID: 15100299 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487 [TBL] [Abstract][Full Text] [Related]
16. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Nardin EH; Oliveira GA; Calvo-Calle JM; Wetzel K; Maier C; Birkett AJ; Sarpotdar P; Corado ML; Thornton GB; Schmidt A Infect Immun; 2004 Nov; 72(11):6519-27. PubMed ID: 15501783 [TBL] [Abstract][Full Text] [Related]
17. A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII. Shiratsuchi T; Rai U; Kaneko I; Zhang M; Iwanaga S; Yuda M; Tsuji M Vaccine; 2017 Dec; 35(50):6990-7000. PubMed ID: 29089194 [TBL] [Abstract][Full Text] [Related]
18. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202 [TBL] [Abstract][Full Text] [Related]
19. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. López JA; Weilenman C; Audran R; Roggero MA; Bonelo A; Tiercy JM; Spertini F; Corradin G Eur J Immunol; 2001 Jul; 31(7):1989-98. PubMed ID: 11449351 [TBL] [Abstract][Full Text] [Related]
20. Identification and Immune Assessment of T Cell Epitopes in Five Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR Front Immunol; 2021; 12():690348. PubMed ID: 34305923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]